marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-07-2024
Cytokinetics, Incorporated Balance Sheet 2011-2024 | CYTK
Annual Balance Sheet Cytokinetics, Incorporated
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-36.7 M | 11.1 M | -50.4 M | 55.5 M | 282 M | 157 K | 50.3 M | -37 M | -4.07 M | -20.2 M | -20.2 M | -14.9 M | -18.7 M |
Long Term Debt |
58.4 M | 63.8 M | 47.4 M | 136 M | 129 M | 39.8 M | 31.8 M | 27.4 M | 14.6 M | - | - | - | - |
Long Term Debt Current |
17.9 M | 12.8 M | 14.9 M | 2.78 M | 4.62 M | 2.61 M | - | 2.5 M | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 275 M | 163 M | 153 M | 42.5 M | 15 M | 17 M | 2.04 M | 361 K | 3 K |
Total Current Liabilities |
103 M | 84.6 M | 71.9 M | 31.2 M | 26 M | 22.2 M | 32.4 M | 33.3 M | 31.6 M | 23.9 M | 26.7 M | 7.1 M | 4.59 M |
Total Liabilities |
1.21 B | 1.12 B | 597 M | 420 M | 301 M | 185 M | 185 M | 75.8 M | 46.6 M | 40.9 M | 28.7 M | 7.47 M | 4.6 M |
Deferred Revenue |
- | - | - | - | - | - | 9.57 M | 8.06 M | 20.9 M | 17 M | 14.7 M | 76 K | - |
Retained Earnings |
-2.11 B | -1.59 B | -1.21 B | -992 M | -865 M | -743 M | -646 M | -518 M | -535 M | -497 M | -483 M | -449 M | -409 M |
Total Assets |
824 M | 1.01 B | 841 M | 534 M | 290 M | 211 M | 295 M | 170 M | 115 M | 133 M | 83.2 M | 77.6 M | 52.8 M |
Cash and Cash Equivalents |
113 M | 65.6 M | 113 M | 83 M | 36.4 M | 42.3 M | 125 M | 66.9 M | 65.1 M | 20.2 M | 20.2 M | 14.9 M | 18.8 M |
Book Value |
-386 M | -108 M | 244 M | 113 M | -10.9 M | 25.9 M | 110 M | 94.4 M | 68.6 M | 92.1 M | 54.4 M | 70.1 M | 48.2 M |
Total Shareholders Equity |
-386 M | -108 M | 244 M | 113 M | -10.9 M | 25.9 M | 110 M | 94.4 M | 68.6 M | 92.1 M | 54.4 M | 70.1 M | 48.2 M |
All numbers in USD currency
Quarterly Balance Sheet Cytokinetics, Incorporated
| 2024-Q3 | 2024-Q2 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
93 M | 92.8 M | 60.9 M | 62.5 M | 64.1 M | 63.8 M | 63.5 M | - | 61.2 M | 47.4 M | 30.2 M | 35.5 M | 40.9 M | 46.2 M | 46.2 M | 46.2 M | 46.2 M | 45.1 M | 45.1 M | 45.1 M | 45.1 M | 39.8 M | 39.8 M | 39.8 M | 39.8 M | 31.8 M | 31.8 M | 31.8 M | 31.8 M | 27.4 M | 27.4 M | 27.4 M | 27.4 M | 14.6 M | 14.6 M | 14.6 M | 14.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
1.45 B | 1.42 B | 1.18 B | 1.11 B | 1.12 B | 1.12 B | 1.09 B | - | 740 M | 597 M | 579 M | 548 M | 509 M | 420 M | 420 M | 420 M | 420 M | 301 M | 301 M | 301 M | 301 M | 185 M | 185 M | 185 M | 185 M | 185 M | 185 M | 185 M | 185 M | 75.8 M | 75.8 M | 75.8 M | 75.8 M | 46.6 M | 46.6 M | 46.6 M | 46.6 M | 40.9 M | 40.9 M | 40.9 M | 40.9 M | 28.7 M | 28.7 M | 28.7 M | 28.7 M | 7.47 M | 7.47 M | 7.47 M | 7.47 M | 4.6 M | 4.6 M | 4.6 M | 4.6 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 4.51 M | 9.57 M | 9.57 M | 9.57 M | 9.57 M | 8.06 M | 8.06 M | 8.06 M | 8.06 M | 20.9 M | 20.9 M | 20.9 M | 20.9 M | 17 M | 17 M | 17 M | 17 M | 14.7 M | 14.7 M | 14.7 M | 14.7 M | 76 K | 129 K | - | - | - | - | 263 K | - |
Retained Earnings |
-2.55 B | -2.39 B | -1.98 B | -1.85 B | -1.72 B | -1.59 B | -1.45 B | - | -1.29 B | -1.21 B | -1.18 B | -1.1 B | -1.04 B | -992 M | -992 M | -992 M | -992 M | -865 M | -865 M | -865 M | -865 M | -743 M | -743 M | -743 M | -743 M | -646 M | -646 M | -646 M | -646 M | -518 M | -518 M | -518 M | -518 M | -535 M | -535 M | -535 M | -535 M | -497 M | -497 M | -497 M | -497 M | -483 M | -483 M | -483 M | -483 M | -449 M | -449 M | -449 M | -449 M | -409 M | -409 M | -409 M | -409 M |
Total Assets |
1.44 B | 1.52 B | 741 M | 780 M | 890 M | 1.01 B | 1.08 B | - | 856 M | 841 M | 828 M | 564 M | 577 M | 534 M | 534 M | 534 M | 534 M | 290 M | 290 M | 290 M | 290 M | 211 M | 211 M | 211 M | 211 M | 295 M | 295 M | 295 M | 295 M | 170 M | 170 M | 170 M | 170 M | 115 M | 115 M | 115 M | 115 M | 133 M | 133 M | 133 M | 133 M | 83.2 M | 83.2 M | 83.2 M | 83.2 M | 77.6 M | 77.6 M | 77.6 M | 77.6 M | 52.8 M | 52.8 M | 52.8 M | 52.8 M |
Cash and Cash Equivalents |
46.9 M | 190 M | 99.7 M | 68.6 M | 102 M | 65.6 M | 106 M | - | 115 M | 113 M | 90.6 M | 37.2 M | 44.6 M | 83 M | 83 M | 83 M | 83 M | 36.4 M | 36.4 M | 36.4 M | 36.4 M | 42.3 M | 42.3 M | 42.3 M | 42.3 M | 125 M | 125 M | 125 M | 125 M | 66.9 M | 66.9 M | 66.9 M | 66.9 M | 65.1 M | 65.1 M | 65.1 M | 65.1 M | 20.2 M | 20.2 M | 20.2 M | 20.2 M | 20.2 M | 20.2 M | 20.2 M | 20.2 M | 14.9 M | 14.9 M | 14.9 M | 14.9 M | 18.8 M | 18.8 M | 18.8 M | 18.8 M |
Book Value |
-13.9 M | 109 M | -439 M | -333 M | -229 M | -108 M | -16 M | - | 116 M | 244 M | 249 M | 16.5 M | 67.8 M | 113 M | 113 M | 113 M | 113 M | -10.9 M | -10.9 M | -10.9 M | -10.9 M | 25.9 M | 25.9 M | 25.9 M | 25.9 M | 110 M | 110 M | 110 M | 110 M | 94.4 M | 94.4 M | 94.4 M | 94.4 M | 68.6 M | 68.6 M | 68.6 M | 68.6 M | 92.1 M | 92.1 M | 92.1 M | 92.1 M | 54.4 M | 54.4 M | 54.4 M | 54.4 M | 70.1 M | 70.1 M | 70.1 M | 70.1 M | 48.2 M | 48.2 M | 48.2 M | 48.2 M |
Total Shareholders Equity |
-13.9 M | 109 M | -439 M | -333 M | -229 M | -108 M | -16 M | 111 M | 116 M | 244 M | 249 M | 16.5 M | 67.8 M | 113 M | 113 M | 113 M | 113 M | -10.9 M | -10.9 M | -10.9 M | -10.9 M | 25.9 M | 25.9 M | 25.9 M | 25.9 M | 110 M | 110 M | 110 M | 110 M | 94.4 M | 94.4 M | 94.4 M | 94.4 M | 68.6 M | 68.6 M | 68.6 M | 68.6 M | 92.1 M | 92.1 M | 92.1 M | 92.1 M | 54.4 M | 54.4 M | 54.4 M | 54.4 M | 70.1 M | 70.1 M | 70.1 M | 70.1 M | 48.2 M | 48.2 M | 48.2 M | 48.2 M |
All numbers in USD currency